4.4 Article

Upregulated FFAR4 correlates with the epithelial-mesenchymal transition and an unfavorable prognosis in human cholangiocarcinoma

Related references

Note: Only part of the references are listed.
Review Oncology

Cholangiocarcinoma - evolving concepts and therapeutic strategies

Sumera Rizvi et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Oncology

Fatty acid receptor GPR120: a novel marker for human melanoma

Johannes Kleemann et al.

MELANOMA RESEARCH (2018)

Review Pharmacology & Pharmacy

For Better or Worse: FFAR1 and FFAR4 Signaling in Cancer and Diabetes

J. M. Houthuijzen

MOLECULAR PHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Different roles of GPR120 and GPR40 in the acquisition of malignant properties in pancreatic cancer cells

Kaori Fukushima et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Gastroenterology & Hepatology

Intrahepatic Cholangiocarcinoma: expert consensus statement

Sharon M. Weber et al.

Article Gastroenterology & Hepatology

Hilar Cholangiocarcinoma: expert consensus statement

John C. Mansour et al.

Article Pharmacology & Pharmacy

Omega-3 Fatty Acids and Other FFA4 Agonists Inhibit Growth Factor Signaling in Human Prostate Cancer Cells

Ze Liu et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)

Review Biochemistry & Molecular Biology

Role of free fatty acid receptors in the regulation of energy metabolism

Takafumi Hara et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)

Review Pharmacology & Pharmacy

Free fatty acid receptors as therapeutic targets for the treatment of diabetes

Atsuhiko Ichimura et al.

FRONTIERS IN PHARMACOLOGY (2014)

Review Oncology

Regulatory networks defining EMT during cancer initiation and progression

Bram De Craene et al.

NATURE REVIEWS CANCER (2013)

Editorial Material Cell Biology

Omega 3 Fatty Acids and GPR120

Da Young Oh et al.

CELL METABOLISM (2012)

Review Chemistry, Medicinal

Free Fatty Acid Receptors FFAR1 and GPR120 as Novel Therapeutic Targets for Metabolic Disorders

Takafumi Hara et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2011)